SuperworthLexeo Therapeutics shares outstanding LXEO
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 85.6M
- On a year earlier
- +96.5%
- more shares
Lexeo Therapeutics had 85.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 96.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 76.4M | +131% |
| FY2024 | 33.1M | +1911% |
| FY2022 | 1.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 85.6M | +97% | |
| Q1 FY26 | 81.2M | +145% | |
| Q4 FY25 | 76.4M | +131% | |
| Q3 FY25 | 61M | +84% | |
| Q2 FY25 | 43.6M | +32% | |
| Q1 FY25 | 33.1M | +18% | |
| Q4 FY24 | 33.1M | n/a | |
| Q3 FY24 | 33.1M | +1932% | |
| Q2 FY24 | 33M | +1938% | |
| Q1 FY24 | 28M | +1637% | |
| Q3 FY23 | 1.6M | −1% | |
| Q2 FY23 | 1.6M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lexeo Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.